Interestingly, CD8+ ILT2+ T cells in the TME (tumor infiltrating lymphocytes, TIL) show a more mature and aggressive CTL phenotype with a higher cytolytic capacity compared to ILT2-negative peripheral blood precursors or CD8+ PD-1+ TIL. Here, LILRB1 is linked to neoplasm.